Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia

Vaccine

Volumn 26, Issue 35, 2008, Pages 4456-4460

  Liu, Wei ^a   Clemens, John D ^a   Kari, Komang ^b   Xu, Zhi Yi ^a,c  

^a International Vaccine Institute   (South Korea)

^b Sanglah Hospital   (Indonesia)

^c FUDAN UNIVERSITY   (China)

Author keywords

Cost benefit analysis; Immunization program; Japanese encephalitis vaccines

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DRUG COST; DRUG EFFICACY; EPIDEMIC ENCEPHALITIS; HEALTH PROGRAM; HUMAN; IMMUNIZATION; INDONESIA; JAPANESE ENCEPHALITIS VIRUS; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; THEORETICAL SAMPLE; UNSPECIFIED SIDE EFFECT;

CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COST-BENEFIT ANALYSIS; ENCEPHALITIS, JAPANESE; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INDONESIA; INFANT; INFANT, NEWBORN; JAPANESE ENCEPHALITIS VACCINES;

EID: 48649098622     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.06.050     Document Type: Article

References (22)

1. Kari K., Liu W., Gautama K., Mammen Jr. M.P., Clemens J.D., Nisalak A., et al. A hospital-based surveillance for Japanese encephalitis in Bali, Indonesia. BMC Med 4 (2006) 8
2. Hsieh W.C., Wang S.P., and Rasmussen A.F. Epidemiology of Japanese encephalitis (JE) on Taiwan in 1960. J Formos Med Assoc 60 (1961) 825-830
3. Wu Y.C., Huang Y.S., Chien L.J., Lin T.L., Yueh Y.Y., Tseng W.L., et al. The epidemiology of Japanese encephalitis on Taiwan during 1966-1997. Am J Trop Med Hyg 61 1 (1999) 78-84
4. Endy T.P., and Nisalak A. Japanese encephalitis virus: ecology and epidemiology. Curr Top Microbiol Immunol 267 (2002) 11-48
5. Wang J.L., Na J.C., Zhao S.S., Wang J., Zhang K.Z., Wang W.L., et al. An epidemiological study of the efficacy of live Japanese encephalitis vaccine. Chin J Biol 6 (1993) 36-37
6. Zhou Bl, Zhang M., and Chen P.Q. An 11-year follow-up of epidemiological effect of live-attenuated Japanese encephalitis vaccine (SA-14-14-2). Chin J Biol 14 3 (2001) 183-185
7. Hennessy S., Liu Z., Tsai T.F., Strom B.L., Wan C.M., Liu H.L., et al. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study. Lancet 347 (June 8) 9015 (1996) 1583-1586
8. Bista M.B., Banerjee M.K., Shin S.H., Tandan J.B., Kim M.H., Sohn Y.M., et al. Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study. Lancet 358 (September 8) 9284 (2001) 791-795
9. Huang Z.L., Li X.G., Wu J.N., and Deng H.F. Side effects of live-attenuated Japanese encephalitis vaccine. Chin J Zoonosis 14 (1998) 60-61
10. Ma W.X., Yu Y.X., Wang S.G., Zhou B.L., Ma Y.H., Feng S.Y., et al. Safety and efficacy of live-attenuated Japanese encephalitis vaccine. Chin J Biol 6 (1993) 245-248
11. Xie G.Z. Japanese encephalitis. In: Zha W.Y. (Ed). Expanded program on immunization Shanghai (1997), Shanghai Science and Technical Publishing Company 402-409
12. Ding D., Kilgore P.E., Clemens J.D., Wei L., and Zhi-Yi Xu. Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China. Bull World Health Organ 81 5 (2003) 334-342
13. Haddix A.C., Teutsch S.M., Shaffer P.A., and Dunet D.O. Prevention effectiveness: a guide to decision analysis and economic evaluation (1996), Oxford University Press, New York
14. Tsai A.C. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, October 13-15, 1998. Vaccine 18 (May 26) Suppl. 2 (2000) 1-25
15. Liu W., Clemens J.D., Yang J.Y., and Xu Z.Y. Immunization against Japanese encephalitis in China: a policy analysis. Vaccine 24 24 (2006) 5178-5182
16. Lopez A.D., Salomon J., Ahmad O., Murray C.J.L., and Mafat D. Life tables for 191 countries: data, methods ad results (2001), World Health Organization, Genera
17. Tandan J.B., Ohrr H., Sohn Y.M., Yoksan S., Ji M., Nam C.M., et al. Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. Vaccine 25 27 (2007) 5041-5045
18. World Development Report, 1993: investing in health (1993), Oxford University Press, Washington, DC
19. World Health Organization. World Health Report 2002: reducing risks, promoting healthy life (2002), World Health Organization, Geneva
20. http://www.adb.org/statistics/icp/files/gni_pc.pdf. Accessed on July 3, 2007.
21. Siraprapasiri T., Sawaddiwudhipong W., and Rojanasuphot S. Cost benefit analysis of Japanese encephalitis vaccination program in Thailand. Southeast Asian J Trop Med Public Health 28 (March) 1 (1997) 143-148
22. Miller M. An assessment of the value of Haemophilus influenza type b conjugate vaccine in Asia. Pediatr Infect Dis J 17 (1998) S152-S159